CORR Insights ®: Diabetes Disease Severity Was Not Associated with Risk of Deep Infection or Revision After Shoulder Arthroplasty.

CORR Insights®: Diabetes Disease Severity Was Not Associated with Risk of Deep Infection or Revision After Shoulder Arthroplasty. Clin Orthop Relat Res. 2019 Jun;477(6):1370-1371 Authors: Bisicchia S PMID: 31136436 [PubMed - in process]
Source: Clinical Orthopaedics and Related Research - Category: Orthopaedics Authors: Tags: Clin Orthop Relat Res Source Type: research

Related Links:

Publication date: Available online 24 September 2020Source: Microvascular ResearchAuthor(s): Lauren Van Hove, Kirsten R. Kim, Denise M. Arrick, William G. Mayhan
Source: Microvascular Research - Category: Biochemistry Source Type: research
Authors: Li L, Sun W, Han M, Ying Y, Wang Q Abstract BACKGROUND Early and rapid identification of severe coronavirus disease 2019 (COVID-19) cases is important. The present study aimed to investigate the predictors of disease severity and thus determine the trends for disease progression early. MATERIAL AND METHODS Patients with COVID-19 were recruited from Fuyang Second People's Hospital from January to February 2020. Patients' demographic, epidemiological, and clinical data were collected, and the relationships between these variables and disease severity were analyzed. RESULTS A total of 158 cases were included ...
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
Conditions:   Reflexology;   Neuropathic Pain Interventions:   Other: Reflexology;   Other: Control Sponsor:   Istanbul Saglik Bilimleri University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: HSK7653 10 mg Q2W;   Drug: HSK7653 25 mg Q2W;   Drug: Linagliptin 5 mg QD Sponsor:   Sichuan Haisco Pharmaceutical Group Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: ORMD-0801;   Other: Placebo Sponsor:   Oramed, Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Diabetic Foot Ulcer;   Diabetic Foot Interventions:   Other: Medaxis Debritom+;   Other: Sharp Surgical Debridement;   Other: Additional Outer Dressing Application;   Other: Offloading;   Other: Fibracol Wound Dressing Sponsors:   Professional Education and Research Institute;   Medaxis AG Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Type2 Diabetes;   NAFLD Intervention:   Dietary Supplement: protein supplement Sponsor:   Charite University, Berlin, Germany Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
In a large study of commercial and private pilots with diabetes who followed strict rules, 98% of glucose levels were in target range and no pilot was incapacitated.Medscape Medical News
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Diabetes & Endocrinology News Source Type: news
Publication date: Available online 24 September 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Mohammad Shafi Kuchay, Narendra Singh Choudhary, Sunil Kumar Mishra
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
Publication date: Available online 24 September 2020Source: Canadian Journal of DiabetesAuthor(s): M.M. MacPherson, T.E. Dineen, K.D. Cranston, M.E. Jung
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
More News: Diabetes | Endocrinology | Orthopaedics